On the in Vitro and in Vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone

Endocrinology

Volumn 114, Issue 5, 1984, Pages 1537-1545

  Bowers, C Y ^a   Momany, F A ^a,b,c   Reynolds, G A ^a   Hong, A ^a,b,c  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MEMPHIS   (United States)

^c BECKMAN COULTER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; HEXAPEPTIDE; NEW DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; CATTLE; CHICKEN; ENDOCRINE SYSTEM; HYPOPHYSIS; IN VITRO STUDY; MONKEY; NONHUMAN; RAT; SHEEP;

ANIMAL; BODY WEIGHT; CATTLE; CHICKENS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GROWTH HORMONE; HORMONES, SYNTHETIC; MACACA MULATTA; MALE; OLIGOPEPTIDES; PITUITARY GLAND; RATS; RATS, INBRED STRAINS; SHEEP; SPECIES SPECIFICITY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0021322884     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/endo-114-5-1537     Document Type: Article

References (21)

1. Momany FA, Bowers CY, Reynolds GA, Chang D, Hong A, Newlander K 1980 Design, synthesis and biological activity of peptides which release growth hormone, in vitro. Endocrinology 108: 31
2. Bowers CY, Reynolds GA, Chang D, Hong A, Chang K, Momany FA 1980 A study on the regulation of GH release from the pituitary of rats, in vitro. Endocrinology 108: 1071
3. Brazeau P, Bohlen P, Ling N, Esch F, Benoit R, Guillemin R, Purification and partial characterization of the hypothalamic growth hormone releasing factor. Program of the 63rd Annual Meeting of The Endocrine Society, Cincinnati, OH, 1981, p 292 (Abstract)
4. Guillemin R, Brazeau P, Bohlen P, Esch F, Ling N, Wehrenberg WB 1982 Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. Science 218: 585
5. Rivier J, Spiess J, Thorner M, Vale W 1982 Characterization of a growth hormone-releasing factor from a human pancreatic islet tumor. Nature 300: 276
6. Wehrenberg WB, Brazeau P, Luben R, Bohlen P, Guillemin R 1982 Inhibition of the pulsatile secretion of growth hormone by monoclonal antibodies to the hypothalamic growth hormone releasing factor (GRF). Endocrinology 111: 2147
7. Wehrenberg WB, Ling N, Bohlen P, Esch F, Brazeau P, Guillemin R 1982 Physiological roles of somatocrinin and somatostatin in the regulation of growth hormone secretion. Biochem Biophys Res Commun 109: 562
8. Rivier J, Spiess J, Brown M, Fisher L, Rivier C, Swanson L, Thorner M, Vale W, GRFs and analogs: their isolation, characterization, synthesis and biological activities. Eighth American Peptide Symposium, University of Arizona, Tucson, AZ, 1983, p 237 (Abstract)
9. Vale W, Spiess J, Rivier C, Swanson L, Vaughn J, Rivier J, Chemical and biological characterization of rat hypothalamic corticotropic- releasing factor (CRF) and growth hormone releasing factor (GRF). Program of the 65th Annual Meeting of The Endocrine Society, San Antonio, TX, 1983, p 263 (Abstract)
10. Spies J, Rivier J, Vale W 1983 Characterization of rat hypothalamic growth hormone-releasing factor. Nature 303: 532
11. 2 and GRF-40. Biochem Biophys Res Commun 114: 930
12. Bowers CY, Chang J, Momany FA, Folkers K 1977 Effects of the enkephalins and enkephalin analogs on release of pituitary hormones in vitro. In: Maclntyre I (ed) Proceedings of 6th International Conference on Endocrinology, Molecular Endocrinology. Elsevier/North-Holland, Amsterdam, p 287
13. Bowers CY, Momany FA, Chang D, Hong A, Chang K 1980 Structure activity relationships of a synthetic pentapeptide that specifically releases GH in vitro. Endocrinology 106: 663
14. Hong A, Newlander K, Foster C, Bowers CY, Reynolds GA, Momany F, Synthesis and biological activity of a peptide with growth hormone releasing activity in vitro and its depsipeptide analog. Eighth American Peptide Symposium, University of Arizona, Tucson, AZ, 1983, p 136 (Abstract)
15. Momany FA, Bowers CY, Reynolds GA, Hong A, Newlander K 1984 Conformational energy studies and in vitro and in vivo activity data on active GH releasing peptides. Endocrinology 114: 1531
16. Proudman JA, Wentworth BC 1978 Radioimmunoassay of turkey growth hormone. Gen Comp Endocrinol 36: 194
17. Harris V, Faloona G, Unger R 1978 Glucagon. In: Jaffe BM, Behrman HR (eds) Methods of Hormone RIA. Academic Press, New York, p 643
18. Momany FA, Bowers CY, Reynolds GA, Hong A, Newlander K, Structure-activity studies on small peptides which release GH and others which inhibit the release of GH at the pituitary. 2nd International Symposium on Somatostatin, Athens, Greece, 1981, p 116 (Abstract)
19. Bowers CY, Wu B, Folkers K 1974 Mechanisms involved in release of TSH and other pituitary hormones. In: Stumpf WE, Grant LD (eds) Proceedings of Conference on Neurobiology of CNS-Hormone Interactions, Anatomical Neuroendocrinology. S Karger, Basel, Switzerland, p 333
20. Bowers CY, Reynolds GA, Hong A, Momany F 1983 Studies on pituitary cyclic AMP and GH levels and the release of GH in vitro. In: Bhatnager AS (ed) The Anterior Pituitary Gland. Raven Press, New York, p 165
21. Bowers CY, Momany F, Reynolds GA, In vitro and in vivo activity of a small synthetic peptide with potent GH releasing activity. Program of the 64th Annual Meeting of The Endocrine Society, San Francisco, CA, 1982, p 205 (Abstract)